Paul Davit

Executive Vice President, Human Resources

Print

Paul Davit

Paul Davit has served as Enzon’s executive vice president, human resources since April 2005. From March 2002 to April 2005, Mr. Davit served as Enzon’s senior vice president, human resources. For more than 20 years, Mr. Davit has directed numerous human resource functions within various corporate settings both as a member of executive management as well as in a consulting capacity.

Prior to joining Enzon, Mr. Davit ran a human resources consulting practice. Previously, Mr. Davit worked at Caliber Associates and spent over 12 years with Rhône-Poulenc Rorer, where he served as vice president of human resources for RPR Gencell, Rhône-Poulenc Rorer’s start-up biotechnology division and as vice president of human resources for the North American Pharmaceuticals division. Mr. Davit began his career as a compensation consultant with the Hay Group.

Mr. Davit received a B.S. in psychology and sociology, an M.S. in environmental science, and an M.B.A. in management sciences, all from Drexel University. Mr. Davit is certified as a Senior Professional in Human Resources by the Human Resources Certification Institute.
Search
(ENZN) NASDAQ
Last Trade9.85
Change(%)price+0.04
Volume651943
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 01-21-2009

    Enzon Concludes Tender Offer f...

    Enzon Concludes Tender Offer for a Portion of Its Debt

    click here for more information

  • 09-30-2008

    Enzon's New Oncaspar-IV™ Rec...

    Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
    -- Improved version to expand global potential --

    click here for more information

  • 02-12-2008

    Enzon Pharmaceuticals to Add N...

    Enzon Pharmaceuticals to Add New Independent Director to Board

    click here for more information